Skip to main content
Midas Edge

Onconetix Inc

For the period ended Jun 30, 2024. Filed Aug 29, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2024 · Filed Aug 29, 2024

ONCO$3.58-48.5%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Item 6. Exhibits

The following documents are filed as exhibits to this Report.

EXHIBIT INDEX

Exhibit No.Description
3.1Amended and Restated Certificate of Incorporation filed with Delaware Secretary of State on February 23, 2022.(1)
3.2Certificate of Amendment to the Company’s Second Amended and Restated Certificate of Incorporation(2)
3.3Certificate of Amendment to the Company’s Second Amended and Restated Certificate of Incorporation.(3)
3.4Fourth Amended and Restated Bylaws of the Company.(3)
4.1Form of Inducement PIO(4)
10.1Consulting Agreement, dated June 10, 2024, between the Company and Karina Fedasz.(5)
10.2Form of Inducement Letter.(4)
10.3Forbearance Agreement, dated April 24, 2024, between the Company and Veru.(6)
10.4Amendment to Non-Convertible Debenture, dated April 24, 2024, between the Company and Altos.(6)
31.1*Certification of the Principal Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2*Certification of the Principal Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1**Certification of the Principal Executive Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2**Certification of the Principal Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
99.1Release Agreement, dated June 10, 2024, between the Company and Bruce Harmon(7)
101.INS*Inline XBRL Instance Document.
101.SCH*Inline XBRL Taxonomy Extension Schema Document.
101.CAL*Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF*Inline XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB*Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE*Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).
*Filed herewith.
**Furnished herewith.
(1)Incorporated by reference to the Company’s Current Report on Form 8-K filed with the SEC on February 24, 2022.
(2)Incorporated by reference to the Company’s Current Report on Form 8-K, filed with the SEC on April 24, 2023.
(3)Incorporated by reference to the Company’s Current Report on Form 8-K filed with the SEC on December 21, 2023.
(4)Incorporated by reference to the Company’s Current Report on Form 8-K filed with the SEC on July 11, 2024.
(5)Incorporated by reference to the Company’s Current Report on Form 8-K filed with the SEC on June 14, 2024.
(6)Incorporated by reference to the Company’s Current Report on Form 8-K filed with the SEC on April 26, 2024.
(7)Incorporated by reference to the Company’s Current Report on Form 8-K filed with the SEC on June 13, 2024.
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.